Home・Akciju saraksts・Stryker Corp

Stryker Corp

Atvērts

SektorsVeselības aprūpe

337.76 -0.9

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

334.39

Max

341.74

Galvenie mērījumi
By Trading Economics
Ienākumi	531M 1.3B
Pārdošana	569M 6.6B
P/E Sektora vidējais	35.072 57.002
EPS	3.69
Dividenžu ienesīgums	1.03
Peļņas marža	19.366
Darbinieki	56,000
EBITDA	266M 1.6B

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt (spēcīgs)
Prognoze 12 mēnešiem	+12.82% upside

Dividendes
By Acuity
Dividenžu ienesīgums Sektora vidējais	1.03% 2.22%
Nākamie ieņēmumi	2026. g. 29. okt.
Nākamais dividenžu datums	2026. g. 30. okt.
Nākamais Ex dividenžu datums	2026. g. 29. sept.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	3.6B 133B
Iepriekšējā atvēršanas cena	338.66
Iepriekšējā slēgšanas cena	337.76

Ziņu noskaņojums

By Acuity

61%

39%

296 / 340 Rangs Healthcare

Stryker Corp Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 13. aug. 20:06 UTC

News

Stryker Corp shares declined following Wolfe Research's downgrade to Peer Perform, citing a challenging outlook and tempered growth expectations for the second half of the year.

2026. g. 12. aug. 19:16 UTC

Stryker Corp. shares are lower amid geopolitical tensions and rising crude oil prices, despite remaining above their 20-day moving average.

2026. g. 11. aug. 23:26 UTC

Stryker Corp. shares declined in after-market trading, reflecting broader market trends amid cautious investor sentiment and lower oil prices.

2026. g. 10. aug. 23:06 UTC

Stryker Corp shares are higher in after-market trading, continuing a trend above the 20-day moving average after three consecutive sessions of gains.

2026. g. 7. aug. 20:06 UTC

Stryker Corp shares are higher, supported by declining Treasury yields after July's unemployment rate fell to 4.1%. Earlier, the stock pulled back from session lows.

2026. g. 6. aug. 20:06 UTC

Macro Event

News

Stryker Corp shares are lower as supply chain disruptions impact sales, despite meeting revenue expectations of $6.59 billion and adjusted EPS of $3.69.

2026. g. 5. aug. 23:12 UTC

Stryker Corp shares are lower in after-market hours, reflecting unusual trading behavior and a decline in momentum since Wednesday's close. No specific news was identified.

2026. g. 4. aug. 19:56 UTC

Stryker Corp shares are lower today, reflecting broader market trends amid a significant drop in crude oil prices since Monday's close.

2026. g. 3. aug. 20:03 UTC

News

Stryker Corp shares are higher as Citizens lowers its price target to $400, citing strong Q2 revenue growth despite supply chain challenges.

2026. g. 31. jūl. 23:16 UTC

Stryker Corp shares are higher in after-market trading, showing some volatility. No specific company news has been identified to explain the movement.

2026. g. 30. jūl. 23:41 UTC

Social Media

News

Stryker Corp shares fell in after-market trading despite reporting adjusted EPS of $3.69 and raising full-year guidance to $14.95 to $15.10.

2026. g. 29. jūl. 22:41 UTC

Stryker Corp shares are lower in after-market trading, reversing from earlier gains. The stock remains above its 20-day moving average.

2026. g. 28. jūl. 20:51 UTC

Stryker Corp shares are lower in after-market trading, reversing earlier gains. The stock remains above its 20-day moving average.

2026. g. 27. jūl. 19:06 UTC

Social Media

News

Correlated Moves

Stryker Corp shares reached a 13-week high today, trading higher alongside broader gains in the medical technology sector, including Intuitive Surgical's notable increase.

2026. g. 24. jūl. 23:36 UTC

Stryker Corp shares are lower in after-market hours, with no specific news identified. Market sentiment reflects cautious optimism amid a decrease in initial jobless claims.

2026. g. 22. jūl. 20:46 UTC

Stryker Corp. shares are higher in after-market trading, rebounding from recent declines, though still below the 20-day moving average.

2026. g. 21. jūl. 18:16 UTC

Stryker Corp shares are lower today, following a dip that reached nearly -2%. The stock remains below its 20-day moving average.

2026. g. 20. jūl. 20:41 UTC

Stryker Corp shares are lower in after-market hours with no specific news identified. Broader market dynamics include a decline in the US 10Y Treasury yield.

Salīdzinājums

Cenas izmaiņa

Stryker Corp Prognoze

Cenas mērķis

By TipRanks

12.82% augšup

Prognoze 12 mēnešiem

Vidējais 384.82 USD 12.82%

Augstākais 455 USD

Zemākais 340 USD

Pamatojoties uz 18 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Stryker Corp — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

18 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 18 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Stryker Corp — pēdējo 3 mēnešu laikā.

Noskaņojums

By Acuity

296 / 340 Rangs Veselības aprūpe

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.